Sibi Raj

In Silico Identification of Potent COVID-19 Main Protease Inhibitors from FDA Approved Antiviral Compounds and Active Phytochemicals through Molecular Docking: A Drug Repurposing Approach

Vaishali Chandel, Sibi Raj, Brijesh Rathi et al. · Preprints.org · 2020 · 72 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach

Vaishali Chandel, Sibi Raj, Brijesh Rathi et al. · 2020 · 68 citations

Pharmacy, Bioinformatics, Infectious Diseases +17

Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2

Vaishali Chandel, Prem P. Sharma, Sibi Raj et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 48 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +17

Correlation of SARS-CoV-2 Serology and Clinical Phenotype Amongst Hospitalised Children in a Tertiary Children’s Hospital in India

Aishwarya Venkataraman, Sundaram Balasubramanian, Sulochana Putilibai et al. · Journal of Tropical Pediatrics · 2021 · 18 citations · Full text

Medicine, Infectious Diseases, Pediatrics +13

Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach

Sibi Raj, Vaishali Chandel, Brijesh Rathi et al. · Coronaviruses · 2020 · 13 citations · Full text

Life Sciences, Infectious Diseases, Molecular Virology +11